FDA drafts guidance on multiregional clinical trials in oncology

[cafead]

via In a new draft guidance, the US Food and Drug Administration (FDA) provided recommendations for multiregional clinical trials (MRCTs) in oncology, encouraging sponsors to ensure the results of trials in global oncology clinical development programs that support a marketing application are interpretable to patients in the US.

article source